Management of pain in colorectal cancer patients

Crit Rev Oncol Hematol. 2021 Jan:157:103122. doi: 10.1016/j.critrevonc.2020.103122. Epub 2020 Oct 19.

Abstract

In this review we focus on the pathophysiology of CRC-related pain and discuss currently applied pain management. Pain is a symptom reported by over 70 % of colorectal cancer (CRC) patients. It remains a feared and debilitating consequence of both cancer and cancer-related treatment. There are many options for pain management in CRC, consisting of intravenous, oral or topical medications. In order to address the full spectrum of pain, proper treatment should address the nociceptive, neuropathic and/or psychogenic pain component. Currently available methods do not bring pain relief to satisfying number of patients and, if used improperly, can cause a number of complications. Therefore, future treatments should focus primarily on alleviating pain, but also on reducing possible side effects. In this article we cover recent and promising pharmacological and non- pharmacological developments emerging in the field of CRC treatment.

Keywords: Colorectal cancer; Colorectal cancer pain; Neuropathic pain; Pain management; Treatment.

Publication types

  • Review

MeSH terms

  • Colorectal Neoplasms* / complications
  • Colorectal Neoplasms* / epidemiology
  • Colorectal Neoplasms* / therapy
  • Humans
  • Neuralgia*
  • Pain Management